Naik, V., Darandale, A., & Pal, P. (2026). Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: “Cardiovascular and Renal Benefits and Risks”. Cardiovascular Disease Prevention and Control, 1(1), 29-38. https://doi.org/10.64229/v3v43h95